Pembrolizumab-induced Pure Red Cell Aplasia Successfully Treated with Intravenous Immunoglobulin

We herein report a 64-year-old man who was treated with pembrolizumab for relapsed Hodgkin lymphoma. After the third administration of pembrolizumab, he showed acute anemia with a positive direct anti-globulin test. Because of the markedly erythroid hypoplasia, he was diagnosed with pure red cell ap...

Descripción completa

Detalles Bibliográficos
Autores principales: Isoda, Atsushi, Miyazawa, Yuri, Tahara, Kenichi, Mihara, Masahiro, Saito, Akio, Matsumoto, Morio, Sawamura, Morio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Japanese Society of Internal Medicine 2020
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7492113/
https://www.ncbi.nlm.nih.gov/pubmed/32389947
http://dx.doi.org/10.2169/internalmedicine.4467-20

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7492113/
https://www.ncbi.nlm.nih.gov/pubmed/32389947
http://dx.doi.org/10.2169/internalmedicine.4467-20

Ejemplares similares